铁灭中的RNA m6A修饰:对推进瘤免疫疗法的影响
Jun-Xiao Shi1, Zhi-Chao Zhang1, Hao-Zan Yin2
1The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 200438, China.
Molecular cancer
|September 28, 2024
概括
这篇评论探讨了RNA m6A修饰如何影响铁亡,这是一种细胞死亡过程,对癌症免疫力至关重要. 了解这种联系可以改善耐药癌症的铁酶敏感免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 癌症仍然是全球死亡的主要原因,需要创新的治疗策略.
- 免疫疗法显示出有希望的结果,但面临着有限的反应率和免疫抵抗的挑战.
- 铁,一种依赖于铁的细胞死亡,与瘤免疫环境有关,可以克服治疗耐药性.
研究的目的:
- 要总结RNA m6A修饰对铁灭的调控特征.
- 讨论RNA m6A介导的铁化在瘤细胞对免疫疗法的反应中的作用.
- 确定潜在的目标,以提高免疫疗法在免疫抵抗性恶性瘤的有效性.
主要方法:
- 关于m6ARNA修饰,铁死和免疫治疗的综合文献综述.
- 分析m6A修饰,铁和免疫检查点之间的相互作用.
- 关于癌症中m6A介导的铁亡的当前理解的综合.
主要成果:
- RNA m6A 修改调节了细胞对铁亡的敏感性.
- 异常的m6A修改影响了免疫检查点的表达.
- 诱导铁亡是一种有希望的策略,可以克服对常规癌症治疗的耐药性.
结论:
- 澄清m6A修饰对铁亡的调节,为癌症治疗提供了一种新的方法.
- 向RNA m6A介导的铁化可以提高免疫治疗耐药癌症的疗效.
- 本综述为开发更有效的对铁灭症敏感的免疫疗法提供了见解.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Stability
33.3K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
RNA Editing
8.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
RNA Splicing
56.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.1K


